Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab

被引：1

作者：

Buonamico, E. ^{[1
]}

Dragonieri, S. ^{[1
]}

Sciancalepore, P. I. ^{[2
]}

Carratu, P. ^{[1
]}

Carpagnano, G. E. ^{[1
]}

Resta, O. ^{[1
]}

Gelardi, M. ^{[3
]}

机构：

[1] Univ Bari, Resp Dis, Bari, Italy

[2] Univ Bari, Otolaringol, Bari, Italy

[3] Univ Foggia, Otolaringol, Foggia, Italy

来源：

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2020年 / 34卷 / 06期

关键词：

nasal citology; eosinophils; severe asthma; nasal polyposis; Benralizumab; RHINOSINUSITIS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2353 / 2357

页数：5

共 50 条

[1] Evaluation of the effects of Benralizumab on Nasal Inflammation in Severe Eosinophilic Refractory Asthma and Nasal Polyposis
Candia, Claudio
Coppa, Francesco
D'Amato, Maria
Paris, Debora
Tramice, Annabella
Ambrosino, Pasquale
Molino, Antonio
Di Stefano, Antonino
Motta, Andrea
Maniscalco, Mauro
[J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[2] COMPREHENSIVE RESPONSE TO BENRALIZUMAB BY PATIENTS WITH NASAL POLYPOSIS AND SEVERE, EOSINOPHILIC ASTHMA
Kreindler, J.
Chanez, P.
Bourdin, A.
Burden, A.
Garcia Gil, E.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S29 - S29
[3] Comprehensive Response to Benralizumab by Patients with Nasal Polyposis and Severe, Eosinophilic Asthma
Kreindler, J.
Chanez, P.
Bourdin, A.
Burden, A.
Gil, Garcia E. G.
[J]. PNEUMOLOGIE, 2021, 75 : S34 - S35
[4] Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis
Canonica, Giorgio Walter
Harrison, Tim W.
Chanez, Pascal
Menzella, Francesco
Louis, Renaud
Cosio, Borja G.
Lugogo, Njira L.
Mohan, Arjun
Burden, Annie
Gil, Esther Garcia
[J]. ALLERGY, 2022, 77 (01) : 150 - 161
[5] CLINICAL EFFICACY CHARACTERIZATION OF BENRALIZUMAB FOR PATIENTS WITH NASAL POLYPOSIS AND SEVERE, UNCONTROLLED EOSINOPHILIC ASTHMA
Katial, R.
Siddiqui, S.
Barker, P.
Kwiatek, J.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S26 - S26
[6] Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis
Pelaia, Corrado
Crimi, Claudia
Benfante, Alida
Caiaffa, Maria Filomena
Campisi, Raffaele
Candia, Claudio
Carpagnano, Giovanna Elisiana
Carrieri, Isabella
D'Amato, Maria
Detoraki, Aikaterini
Barbaro, Maria Pia Foschino
Lombardo, Nicola
Macchia, Luigi
Maglio, Angelantonio
Minenna, Elena
Nolasco, Santi
Paglino, Giuseppe
Papia, Francesco
Ricciardi, Luisa
Scichilone, Nicola
Scioscia, Giulia
Spadaro, Giuseppe
Tondo, Pasquale
Lionetti, Simona Uletta
Valenti, Giuseppe
Vatrella, Alessandro
Crimi, Nunzio
Pelaia, Girolamo
[J]. RESPIROLOGY, 2024,
[7] TOTAL NASAL SYMPTOM SCORE IMPROVEMENT WITH BENRALIZUMAB FOR PATIENTS WITH SEVERE, EOSINOPHILIC ASTHMA
Chipps, B.
Corren, J.
Israel, E.
Barker', P.
Kreindler, J.
Newbold, P.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S24 - S24
[8] EFFICACY OF BENRALIZUMAB IN SEVERE ASTHMA IN REAL LIFE AND FOCUS ON NASAL POLYPOSIS
Bagnasco, D.
Passalacqua, G.
[J]. CHEST, 2020, 157 (06) : 9A - 9A
[9] Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis
Bagnasco, Diego
Brussino, Luisa
Bonavia, Marco
Calzolari, Elisa
Caminati, Marco
Caruso, Cristiano
D'Amato, Maria
De Ferrari, Laura
Di Marco, Fabiano
Imeri, Gianluca
Di Bona, Danilo
Gilardenghi, Andrea
Guida, Giuseppe
Lombardi, Carlo
Milanese, Manlio
Nicolini, Antonello
Riccio, Anna Maria
Rolla, Giovanni
Santus, Pierachille
Senna, Gianenrico
Passalacqua, Giovanni
[J]. RESPIRATORY MEDICINE, 2020, 171
[10] Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis
Bagnasco, Diego
Passalacqua, Giovanni
[J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56

← 1 2 3 4 5 →